Form 4 holding
CEO, Director
Aclaris Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,543,886
- Estimated value
- $5,357,284
- Report date
- 03 Feb 2026
- Price
- $3.47
- Ownership
- Direct
Neal Walker - CEO, Director at Aclaris Therapeutics, Inc.
Issuer-level insider activity
- Role
- CEO, Director
- Issuer ticker
- ACRS on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Neal Walker since 15 Nov 2025
Reported holdings for Neal Walker in Aclaris Therapeutics, Inc.
Form 4 holding
CEO, Director
Aclaris Therapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 190,425
- Estimated value
- $18,839
- Report date
- 03 Feb 2026
- Price
- $1.99
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
CEO, Director
Aclaris Therapeutics, Inc.
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 961,700
- Estimated value
- Report date
- 02 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Neal Walker in Aclaris Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.